| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 69,954 | 72,909 | 71,694 | 87,507 | | Cost of Revenue | 15,460 | 16,596 | 17,606 | 19,787 | | | Gross Profit | 54,494 | 56,313 | 54,088 | 67,720 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| 1,225 | | Selling General and Administrative | 31,549 | 32,261 | 33,684 | 32,092 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 11,447 | 13,149 | 13,210 | 12,967 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,498 | 10,903 | 7,194 | 21,436 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 11,498 | 10,903 | 7,194 | 21,436 | | Interest Expense | 2,235 | 2,121 | 2,348 | 3,411 | | Income Before Tax | 9,263 | 8,782 | 4,846 | 18,025 | | Income Tax Expense | 2,530 | 2,499 | (1,405) | 5,710 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,733 | 6,283 | 6,251 | 12,315 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,733 | 6,283 | 6,251 | 12,315 | | Preferred Stock And Other Adjustments | (1,701) | (1,696) | (1,313) |
-
| | | Net Income Applicable To Common Shares | $5,032 | $4,587 | $4,938 | $12,315 |
|
0.02% Nasdaq 
Income Statement
